Amelogenin-Derived Peptides in Bone Regeneration: A Systematic Review

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Periodontal Surgery

Background:

• Amelogenins are enamel matrix proteins utilized in treating bone defects.
• Amelogenin-derived peptides (LRAP, TRAP, SP, C11) are emerging as key players in bone tissue engineering.
• These peptides may offer enhanced or equivalent biological activity compared to full-length amelogenins.

Purpose of the Study:

• To systematically review evidence on LRAP, TRAP, SP, and C11's ability to induce mineralized extracellular matrix production.
• To narratively review the structure and function of amelogenin and its derived peptides.
• To assess the potential of these peptides in bone regeneration and tissue engineering.

Main Methods:

• Systematic literature review focusing on mineralized extracellular matrix induction.
• Narrative review of amelogenin and amelogenin-derived peptide structure-function relationships.
• Analysis of existing scientific evidence on peptide efficacy in bone regeneration.

Main Results:

• LRAP and SP peptides demonstrate the ability to induce stromal stem cell differentiation into osteoblastic phenotypes.
• SP peptide shows particular promise for bone regenerative approaches due to its osteoinductive properties and lack of immunogenicity.
• Limited studies and a scarcity of in vivo data currently exist for these peptides.

Conclusions:

• Amelogenin-derived peptides, particularly SP, show potential for bone tissue engineering and regeneration.
• Further in vivo investigations are crucial to establish a definitive conclusion on their therapeutic efficacy.
• The immunogenicity and osteoinductive capacity of SP warrant continued research for periodontal applications.